Hugel Inc 145020
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- ₩180,600.00
- Day Range
- ₩179,400.00–183,700.00
- 52-Week Range
- ₩175,500.00–306,500.00
- Bid/Ask
- ₩180,600.00 / ₩180,100.00
- Shares Outstanding
- 10.80M
- Market Cap
- ₩1.95T
- Volume/Avg
- 39,279 / 51,084
Key Statistics
- Price/Earnings (Normalized)
- 12.22
- Price/Sales
- 4.25
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- 0.07%
Company Profile
Hugel Inc is a biopharmaceutical company. It is in the business of manufacturing medical aesthetics, specializing in the production of injectables for skin rejuvenation, including botulinum toxin, hyaluronic acid fillers, and skin boosters, as well as absorbable sutures and cosmetic products. Geographically, it has a presence in the U.S., Australia, Canada, Taiwan, China, Hong Kong, Singapore, and Thailand.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Core
- Total Number of Employees
- 625
- Website
- https://www.hugel-inc.com
Valuation
|
Metric
|
145020
|
|---|---|
Price/Earnings (Normalized) | 12.22 |
Price/Book Value | 1.88 |
Price/Sales | 4.25 |
Price/Cash Flow | 9.41 |
Price/Earnings
145020
Financial Strength
|
Metric
|
145020
|
|---|---|
Quick Ratio | 6.91 |
Current Ratio | 7.55 |
Interest Coverage | 197.50 |
Quick Ratio
145020
Profitability
|
Metric
|
145020
|
|---|---|
Return on Assets (Normalized) | 16.14% |
Return on Equity (Normalized) | 18.72% |
Return on Invested Capital (Normalized) | 16.42% |
Return on Assets
145020
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|m>rWk@W | LOCK|<>>@m | $128B | |||
| Moderna Inc
MRNA
| LOCK|hPd^@M | LOCK|ZWT | $76B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|nQnr^p | LOCK|F&?t | $76B | |||
| argenx SE ADR
ARGX
| LOCK|&#ZdGS | LOCK|Xf% | $57B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|&?#GS@& | LOCK|R# | $41B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|YLq%FN^ | LOCK|$x$Q | $29B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|@$rKSmx$ | LOCK|Q#c!$ | $25B | |||
| BioNTech SE ADR
BNTX
| LOCK|%S$S&T? | LOCK|T<z | $24B | |||
| Incyte Corp
INCY
| LOCK|@QNWdt | LOCK|%J | $23B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|fd#?bSf | LOCK|@km | $15B |
United States